Health Canada To Investigate Relenza

Law360, New York (April 10, 2008, 12:00 AM EDT) -- Amid growing worldwide concern over anti-flu drugs, Health Canada has reportedly decided to take a harder look at Relenza in the wake of reports that it can lead to psychotic reactions.

Health Canada opted to take the additional safety step even though the Canadian federal agency updated the labeling for GlaxoSmithKline’s Relenza last month, News Inferno reported on Wednesday.

The U.S. Food and Drug Administration expressed concern in November about the potential side effects of numerous anti-flu drugs.

A majority of the FDA’s Pediatric Advisory Committee...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.